Elevai Labs Inc (ELAB): Price-to-Revenue Ratio

Symbol and logo of brand Elevai Labs Inc (ELAB)

Elevai Labs Inc. (ELAB) is implementing AI control and bioreactor automation for exosome production. The P/S time series visualizes market expectations, where 0.50 shows the value of this parameter. The company is testing robotic stations for the purification of placental components. The operating model relies on contract cosmetics manufacturing and cloud IT outsourcing to promote innovative serums.

ELAB elevaiskincare.com Market Cap to Revenue (02/21/2024 - 11/13/2026)

Analytical breakdowns for Elevai Skincare (ELAB)

- current quotes and average value forecast:
Market Price elevaiskincare.com|ELAB - Price Target Chart
- stock exchange capitalization data:
Market Value Elevai Skincare|ELAB - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share Elevai Labs|ELAB - Company Net Assets|Market Value to Book Value Ratio elevaiskincare.com|ELAB - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Elevai Labs Inc.|ELAB - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Elevai Corp|ELAB - Company Total Debt|Debt to Net Assets Ratio Elevai Skincare|ELAB - Company Long-Term Debt|Company Short-Term Debt Elevai Labs|Quick Ratio elevaiskincare.com
- earnings and multiples data:
ELAB - Net Profit|Expected Profit Elevai Labs Inc.|ELAB - Price to Earnings Ratio|Market Cap to Projected Earnings Elevai Labs Inc|ELAB - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Elevai Skincare|ELAB - Operating profit EBITDA|Net earnings per share for the last four quarters Elevai Labs|ELAB - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months elevaiskincare.com|ELAB - Earnings growth in current year|Expected earnings per share growth for next year Elevai Labs Inc.
- sales revenue and business income indicators:
ELAB - Company Sales|Company Future Sales elevaiskincare.com|ELAB - P/S Multiple|Market Cap to Future Revenue Ratio Elevai Skincare
Summary company analytics:elevaiskincare.com, ELAB
Signature product of Elevai Labs Inc.

Scaling retail serum sales through alliances with plastic surgery clinics is directly reflected in the P/S multiple dynamics. This ratio correlates the market value of Elevai Labs Inc. (ELAB) with its total revenue, allowing investors to decouple speculative price growth from actual revenue increases and determine the extent of the asset's fundamental overvaluation or undervaluation.

Competitors of Elevai Labs Inc.

KRYS - Price to Sales|Price-to-Revenue Ratio Apogee Therapeutics, Inc. APGE|Arcutis - Price-to-Revenue Ratio|Vericel Corp. - P/S Multiple|Price to Sales Oruka Pharma|SMTI (sanaramedtech.com) - Market Cap to Revenue|DBVT (DBV Technologies) - Price-to-Revenue Ratio|SLSN (Solesence Beauty) - P/S Multiple|P/S Multiple Journey Medical Corp.|P/S Multiple FBRX|Price-to-Revenue Coefficient Empro Corporation|Sol-Gel Technologies - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio AXIL|MDCX - Price-to-Revenue Ratio|VRCA: Price-to-Revenue Ratio|HOTH: P/S Multiple|Biofrontera (BFRI) - P/S Multiple|VYNE (VYNE Therapeutics, Inc.) - P/S Multiple|Price-to-Revenue Ratio SNOA|Price-to-Revenue Ratio Quoin Pharmaceuticals (QNRX)|Price-to-Revenue Coefficient Azitra Inc|Dermata - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio RVNC